237 related articles for article (PubMed ID: 18753675)
1. Chylomicron remnants are increased in the postprandial state in CD36 deficiency.
Masuda D; Hirano K; Oku H; Sandoval JC; Kawase R; Yuasa-Kawase M; Yamashita Y; Takada M; Tsubakio-Yamamoto K; Tochino Y; Koseki M; Matsuura F; Nishida M; Kawamoto T; Ishigami M; Hori M; Shimomura I; Yamashita S
J Lipid Res; 2009 May; 50(5):999-1011. PubMed ID: 18753675
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of ezetimibe-induced attenuation of postprandial hypertriglyceridemia.
Sandoval JC; Nakagawa-Toyama Y; Masuda D; Tochino Y; Nakaoka H; Kawase R; Yuasa-Kawase M; Nakatani K; Inagaki M; Tsubakio-Yamamoto K; Ohama T; Matsuyama A; Nishida M; Ishigami M; Komuro I; Yamashita S
J Atheroscler Thromb; 2010 Sep; 17(9):914-24. PubMed ID: 20543519
[TBL] [Abstract][Full Text] [Related]
3. Fenofibrate reduces postprandial hypertriglyceridemia in CD36 knockout mice.
Sandoval JC; Nakagawa-Toyama Y; Masuda D; Tochino Y; Nakaoka H; Kawase R; Yuasa-Kawase M; Nakatani K; Inagaki M; Tsubakio-Yamamoto K; Ohama T; Nishida M; Ishigami M; Komuro I; Yamashita S
J Atheroscler Thromb; 2010 Jun; 17(6):610-8. PubMed ID: 20351468
[TBL] [Abstract][Full Text] [Related]
4. A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice.
Sairyo M; Kobayashi T; Masuda D; Kanno K; Zhu Y; Okada T; Koseki M; Ohama T; Nishida M; Sakata Y; Yamashita S
J Atheroscler Thromb; 2018 Feb; 25(2):142-152. PubMed ID: 28781340
[TBL] [Abstract][Full Text] [Related]
5. CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine.
Nauli AM; Nassir F; Zheng S; Yang Q; Lo CM; Vonlehmden SB; Lee D; Jandacek RJ; Abumrad NA; Tso P
Gastroenterology; 2006 Oct; 131(4):1197-207. PubMed ID: 17030189
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36.
Hsieh J; Longuet C; Maida A; Bahrami J; Xu E; Baker CL; Brubaker PL; Drucker DJ; Adeli K
Gastroenterology; 2009 Sep; 137(3):997-1005, 1005.e1-4. PubMed ID: 19482026
[TBL] [Abstract][Full Text] [Related]
7. Luminal lipid regulates CD36 levels and downstream signaling to stimulate chylomicron synthesis.
Tran TT; Poirier H; Clément L; Nassir F; Pelsers MM; Petit V; Degrace P; Monnot MC; Glatz JF; Abumrad NA; Besnard P; Niot I
J Biol Chem; 2011 Jul; 286(28):25201-10. PubMed ID: 21610069
[TBL] [Abstract][Full Text] [Related]
8. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.
Karpe F; Hellénius ML; Hamsten A
Metabolism; 1999 Mar; 48(3):301-7. PubMed ID: 10094104
[TBL] [Abstract][Full Text] [Related]
9. Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake.
Bharadwaj KG; Hiyama Y; Hu Y; Huggins LA; Ramakrishnan R; Abumrad NA; Shulman GI; Blaner WS; Goldberg IJ
J Biol Chem; 2010 Dec; 285(49):37976-86. PubMed ID: 20852327
[TBL] [Abstract][Full Text] [Related]
10. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
Björkegren J; Karpe F; Milne RW; Hamsten A
J Lipid Res; 1998 Jul; 39(7):1412-20. PubMed ID: 9684744
[TBL] [Abstract][Full Text] [Related]
11. Dietary fat and physiological determinants of plasma chylomicron remnant homoeostasis in normolipidaemic subjects: insight into atherogenic risk.
Irawati D; Mamo JC; Slivkoff-Clark KM; Soares MJ; James AP
Br J Nutr; 2017 Feb; 117(3):403-412. PubMed ID: 28215212
[TBL] [Abstract][Full Text] [Related]
12. Postprandial lipoproteins and atherosclerosis.
Yu KC; Cooper AD
Front Biosci; 2001 Mar; 6():D332-54. PubMed ID: 11229885
[TBL] [Abstract][Full Text] [Related]
13. Postprandial Hyperlipidemia and Remnant Lipoproteins.
Masuda D; Yamashita S
J Atheroscler Thromb; 2017 Feb; 24(2):95-109. PubMed ID: 27829582
[TBL] [Abstract][Full Text] [Related]
14. Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients.
Cassader M; Gambino R; Musso G; Depetris N; Mecca F; Cavallo-Perin P; Pacini G; Rizzetto M; Pagano G
Lipids; 2001 Oct; 36(10):1117-24. PubMed ID: 11768156
[TBL] [Abstract][Full Text] [Related]
15. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
[TBL] [Abstract][Full Text] [Related]
16. Signposts in the assembly of chylomicrons.
Hussain MM; Kedees MH; Singh K; Athar H; Jamali NZ
Front Biosci; 2001 Mar; 6():D320-31. PubMed ID: 11229873
[TBL] [Abstract][Full Text] [Related]
17. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100.
Karpe F; Bell M; Björkegren J; Hamsten A
Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):199-207. PubMed ID: 7749826
[TBL] [Abstract][Full Text] [Related]
18. CD36 deficiency in mice impairs lipoprotein lipase-mediated triglyceride clearance.
Goudriaan JR; den Boer MA; Rensen PC; Febbraio M; Kuipers F; Romijn JA; Havekes LM; Voshol PJ
J Lipid Res; 2005 Oct; 46(10):2175-81. PubMed ID: 16024917
[TBL] [Abstract][Full Text] [Related]
19. Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk.
Boquist S; Ruotolo G; Hellénius ML; Danell-Toverud K; Karpe F; Hamsten A
Atherosclerosis; 1998 Apr; 137(2):391-400. PubMed ID: 9622282
[TBL] [Abstract][Full Text] [Related]
20. Higher chylomicron remnants and LDL particle numbers associate with CD36 SNPs and DNA methylation sites that reduce CD36.
Love-Gregory L; Kraja AT; Allum F; Aslibekyan S; Hedman ÅK; Duan Y; Borecki IB; Arnett DK; McCarthy MI; Deloukas P; Ordovas JM; Hopkins PN; Grundberg E; Abumrad NA
J Lipid Res; 2016 Dec; 57(12):2176-2184. PubMed ID: 27729386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
